FSLLRY-NH2 Improves Neurological Outcome After Cardiac Arrest in Rats


Ocak U., OCAK P., Huang L., Zhang J. H.

TURKISH NEUROSURGERY, vol.30, no.2, pp.244-251, 2020 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.5137/1019-5149.jtn.27714-19.1
  • Journal Name: TURKISH NEUROSURGERY
  • Journal Indexes: Science Citation Index Expanded, Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.244-251

Abstract

AIM: To evaluate the effect of FSLLRY-NH2, a protease-activated receptor 2 (PAR2) inhibitor, on neurocognitive impairment and hippocampal neuronal degeneration in the setting of asphyxial cardiac arrest (ACA)-induced global cerebral ischemia (GCI) in rats.